Skip to main content
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1977 Oct;20:257–262. doi: 10.1289/ehp.7720257

Pharmacokinetic models for lipophilic compounds.

H B Matthews, D B Tuey, M W Anderson
PMCID: PMC1637340  PMID: 413710

Abstract

In many instances pharmacokinetic modeling offers the best method of interpreting the significance to man of results obtained with laboratory animals but first we must have accurate models for our laboratory animals. A physiological pharmacokinetic model has been used to simulate the disposition of polychlorinated biphenyls (PCBs) in the rat and to extrapolate results obtained with the rat to predict the disposition of PCBs in the mouse. The modeling methods have also been extended to predict the disposition of a polybrominated biphenyl (PBB) in the rat following IV, oral, and multiple oral doses. It is anticipated that with additional experience and work a physiological pharmacokinetic model can be used to predict the disposition of these and other xenobiotics in man.

Full text

PDF
257

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dunckel A. E. An updating on the polybrominated biphenyl disaster in Michigan. J Am Vet Med Assoc. 1975 Nov 1;167(9):838–841. [PubMed] [Google Scholar]
  2. Lutz R. J., Dedrick R. L., Matthews H. B., Eling T. E., Anderson M. W. A preliminary pharmacokinetic model for several chlorinated biphenyls in the rat. Drug Metab Dispos. 1977 Jul-Aug;5(4):386–396. [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES